Aleksandra Sergeevna Orlova

Dr. Aleksandra Sergeevna Orlova

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Open access
MAMihail A. Akulov
Mihail A. Akulov
OOOlga Orlova
Olga Orlova
AOAleksandra Sergeevna Orlova
Aleksandra Sergeevna Orlova
DUDmitriy Usachev
Dmitriy Usachev
VSVadim Shimansky
Vadim Shimansky
AYAnna V. Yunosha-Shanyavskaya
Anna V. Yunosha-Shanyavskaya
This study evaluates the effect of incobotulinumtoxinA in the acute and chronic phases of facial nerve palsy after neurosurgical interventions. Patients received incobotulinumtoxinA injections (active treatment group) or standard rehabilitation treatment (control group). Functional efficacy was assessed using House-Brackmann, Yanagihara System and Sunnybrook Facial Grading scales, and Facial Disability Index self-assessment. Significant improvements on all scales were seen after 1month of incobotulinumtoxinA treatment (active treatment group, р<0.05), but only after 3months of rehabilitation treatment (control group, р<0.05). At 1 and 2years post-surgery, the prevalence of synkinesis was significantly higher in patients in the control group compared with those receiving incobotulinumtoxinA treatment (р<0.05 and р<0.001, respectively). IncobotulinumtoxinA treatment resulted in significant improvements in facial symmetry in patients with facial nerve injury following neurosurgical interventions. Treatment was effective for the correction of the compensatory hyperactivity of mimic muscles on the unaffected side that develops in the acute period of facial nerve palsy, and for the correction of synkinesis in the affected side that develops in the long-term period. Appropriate dosing and patient education to perform exercises to restore mimic muscle function should be considered in multimodal treatment.

18 July 2019 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
DBDmitry V. Blinov
Dmitry V. Blinov
EAE. S. Akarachkova
E. S. Akarachkova
AOAleksandra Sergeevna Orlova
Aleksandra Sergeevna Orlova
EKE. V. Kryukov
E. V. Kryukov
DKD. I. Korabelnikov
D. I. Korabelnikov

7 November 2017 in Neuromuscular Diseases
Verified
Journal Article
Open access
PDF file
SKS. E. Khat’kOva
S. E. Khat’kOva
MAM. A. Akulov
M. A. Akulov
OOO. R. Orlova
O. R. Orlova
DUD. Yu. Usachev
D. Yu. Usachev
AOAleksandra Sergeevna Orlova
Aleksandra Sergeevna Orlova
LKL. V. Krylova
L. V. Krylova
The article reviews the current concept of lower extremity spasticity, which is a frequent disabling consequence of stroke. Gait biomechanics, step cycle and main pathologic patterns of lower extremity are described (hip adduction, knee flexion, knee extension, foot plantar flexion, equinovarus foot position, toes flexion, hallux extension), including muscles involved in the pathological process. Additionally the article contains detailed information on pathologic principles of lower extremity spasticity development. Special focus is given to sarcomeregenesis as an essential element of the development of potential conditions for muscle tissue adaptation to a new state and restoration of muscle length and strength. At present Botulinum toxin A (BTA) is used in a complex spasticity management programs. The results of clinical studies performed in the last decade supporting the efficacy of Botox® (Onabotulinumtoxin A) in the treatment of spasticity are reviewed. Effective BTA doses are proposed. Authors came to the conclusion that BTA as a part of complex rehabilitation in patients with poststroke spasticity of lower extremity promotes treatment efficacy due to a decrease of muscle tone and increase of range of movements in the joints. BTA should be regarded as an essential part of standard rehabilitation programs. Further studies to define optimal muscles for intervention, BTA doses and rehabilitation schemes are still needed.

1 January 2018 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
MAM. A. Akulov
M. A. Akulov
STS. V. Tanyashin
S. V. Tanyashin
VSV. N. Shimansky
V. N. Shimansky
DUD. Yu. Usachev
D. Yu. Usachev
OOO. R. Orlova
O. R. Orlova
AOAleksandra Sergeevna Orlova
Aleksandra Sergeevna Orlova
Medical article медицинская статья

7 September 2023 in Animals
Verified
Journal Article
Open access
PDF file
PRPetar Ristic
Petar Ristic
Maja JovanovicMaja Jovanovic
Maja Jovanovic
SBSergey Bolevich
Sergey Bolevich
SBStefani Bolevich
Stefani Bolevich
AOAleksandra Sergeevna Orlova
Aleksandra Sergeevna Orlova
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
Background: This study explored the effects of hyperbaric oxygen therapy (HBOT) on the cardiovascular system and oxidative stress in streptozotocin-induced diabetic rats. Wistar albino rats were divided into four groups: DM group (diabetic rats), DM+HBOT group (diabetic rats exposed to HBOT for 1 h daily, five days a week, at 2.8 atmosphere absolute (ATA) with 100% oxygen for two weeks), DM+INS group (diabetic rats treated with neutral protamine hagedorn (NPH) insulin at a dosage of 3–5 U/day), and DM+HBOT+INS group (diabetic rats treated with both NPH insulin and HBOT for two weeks). Methods: Evaluations included glycemic control, oxidative stress parameters, and cardiac function measurements. Results: NPH insulin treatment reduced blood glucose levels, although normoglycemia was not achieved. The DM+HBOT+INS group demonstrated the lowest pro-oxidative marker levels. NPH insulin treatment improved cardiac function, and combination therapy effectively restored cardiac function in diabetic animals. Conclusions: NPH insulin treatment reduced hyperglycemia and improved cardiac function in diabetic rats. The combined approach of NPH insulin and HBOT resulted in decreased pro-oxidative markers. These findings provide valuable insights for managing cardiovascular complications and oxidative stress in diabetes.

1 January 2018 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
MAM. A. Akulov
M. A. Akulov
OOO. R. Orlova
O. R. Orlova
TTT. V. Tabashnikova
T. V. Tabashnikova
VKV. V. Karnaukhov
V. V. Karnaukhov
AOAleksandra Sergeevna Orlova
Aleksandra Sergeevna Orlova
Medical article медицинская статья